The US-China trade truce might shift FII investment away from India and towards China. Some analysts warn of reduced India's attractiveness, while others highlight India's structural growth and sectors insulated from China's trade dynamics, such as pharma and IT. The impact on India's manufacturing sector is debated, with concerns over China regaining cost competitiveness.